These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Computer tomography of the pelvis. Basics for radiation-therapy, localization and treatment-planning in carcinoma of the prostate (author's transl)]. Jentsch F; Stringaris K; Kaiser G; Kirschner H Radiologe; 1977 Jun; 17(6):268-70. PubMed ID: 887746 [TBL] [Abstract][Full Text] [Related]
4. [Roentgenotopometry in the radiation therapy of prostate cancer]. Sviridova TV; Dunchik VN; Astapov BM; Mardynskiĭ IuS Med Radiol (Mosk); 1981 Feb; 26(2):36-40. PubMed ID: 7207052 [No Abstract] [Full Text] [Related]
5. Computerized tomography in carcinoma of the prostate: treatment volume and morbidity in radiotherapy. Mak AC; van't Riet A; Stam HC; van Slooten FH Strahlentherapie; 1984 Apr; 160(4):244-5. PubMed ID: 6719513 [TBL] [Abstract][Full Text] [Related]
6. Prostate localization for the treatment planning of prostate cancer: a comparison of two techniques. Murphy DJ; Porter AT Med Dosim; 1988 Mar; 13(1):11-2. PubMed ID: 3252896 [TBL] [Abstract][Full Text] [Related]
7. [Alternative use of the simulator method and computer tomography in planning radiotherapy for non-metastasizing prostatic cancer]. Hodapp N; Hinkelbein W; Slanina J; Wannenmacher M Radiologe; 1984 Jan; 24(1):19-23. PubMed ID: 6709875 [TBL] [Abstract][Full Text] [Related]
8. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer. O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276 [TBL] [Abstract][Full Text] [Related]
9. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer. Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907 [TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656 [TBL] [Abstract][Full Text] [Related]
17. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189 [TBL] [Abstract][Full Text] [Related]
18. PET/CT and radiotherapy in prostate cancer. De Jong IJ; De Haan TD; Wiegman EM; Van Den Bergh AC; Pruim J; Breeuwsma AJ Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):543-52. PubMed ID: 20927021 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes. Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261 [TBL] [Abstract][Full Text] [Related]